Prop. 38 would borrow $8.4 billion for immune-system research, with half reserved for a single institute
Backers of the Nov. 3 bond measure say immunotherapy could lead to cures for cancer and Alzheimer's; critics question tying half the money to one UCLA-affiliated nonprofit. Repayment would cost $500 million to $600 million a year.